Depending on exactly how the process works, the ability to treat a lot of degenerative diseases fairly simply and presumably fewer beds required for long term care, the economics of life extension might work out as a net positive. Dying is expensive, so if you largely eliminate that cost it can change things and the current “cure aging in mice” research looks to be a fairly simple process that may scale quite well.